Company: LCTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0000950170-25-060090
Chunk: 0

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

| Filed by the Registrant ☒ | Filed by a Party other than the Registrant ☐ |

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement                                                      |
| ☐ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material Pursuant to §240.14a-12                                     |

Lineage Cell Therapeutics, Inc. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement if other than the Registrant) Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required.                                                                                    |
| ☐ | Fee paid previously with preliminary materials.                                                     |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

| 2173 Salk Ave., Suite 200Carlsbad, CA 92008(442) 287-8990www.lineagecell.com |

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held June 26, 2025 To the Shareholders of Lineage Cell Therapeutics, Inc.: The 2025 annual meeting of shareholders (the “ Meeting ”) of Lineage Cell Therapeutics, Inc. (“ Lineage ,” “ we ,” “ us ,” and “ our ”) will be held at 2173 Salk Avenue, Suite 200, Carlsbad, CA 92008 on June 26, 2025 at 8:00 a.m. Pacific Time for the following purposes: 1. To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified. The nominees are Michael H. Mulroy, Dipti Amin, Deborah Andrews, Neal C. Bradsher, Brian M. Culley, Anula Jayasuriya, and Angus C. Russell. 2. To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for our fiscal year ending December 31